HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling PathwayJunhua Li, Ximing Xu|Frontiers in Oncology|2021Cited by 46
Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cellsXiaoqin He, Ximing Xu|Oncotarget|2016Cited by 27
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trialChuanhua Zhao, Chuan Jin, Zhendong Zheng et al.|Signal Transduction and Targeted Therapy|2025Cited by 20
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysisHuilin Xu, Wei Ge, Dedong Cao et al.|Annals of Translational Medicine|2023Cited by 0